Cenicriviroc

Cenicriviroc
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
Cay23927-500 500 µg -

6 - 10 Werktage*

81,00 €
Cay23927-1 1 mg -

6 - 10 Werktage*

125,00 €
Cay23927-5 5 mg -

6 - 10 Werktage*

461,00 €
Cay23927-10 10 mg -

6 - 10 Werktage*

841,00 €
 
Cenicriviroc is an orally bioavailable antagonist of C-C chemokine receptor type 5 (CCR5) and... mehr
Produktinformationen "Cenicriviroc"
Cenicriviroc is an orally bioavailable antagonist of C-C chemokine receptor type 5 (CCR5) and CCR2 that inhibits binding of macrophage inflammatory protein 1alpha (MIP-1alpha, IC50 = 2.3 nM) and monocyte chemotactic protein 1 (MCP-1, IC50 = 5.9 nM), respectively, in CHO cells. Cenicriviroc is also an antagonist of CCR3 and CCR4 (IC50s = 2.4 and 1.1 µM, respectively), however, it does not inhibit agonist binding to CCR1 or CCR7 at concentrations up to 10 µM. At a concentration of 100 nM, cenicriviroc completely inhibits replication of R5 HIV-1 in U87.CD4.CCR5 cells. Cenicriviroc inhibits replication of the R5 HIV-1 strains JR-FL and KK in peripheral blood mononuclear cells (PBMCs) with EC50 values ranging from 21 to 210 pM and 33 to 91 pM, respectively. In vivo, cenicriviroc (20 mg/kg per day) reduces collagen deposition, levels of collagen type 1 protein and mRNA expression, and non-alcoholic fatty liver disease activity score in a mouse model of non-alcoholic steatohepatitis (NASH). It also reduces collagen type 1 protein levels, mRNA expression, and collagen deposition in a mouse model of unilateral ureter obstruction and a rat model of thioacetamide-induced liver fibrosis.Formal Name: 8-[4-(2-butoxyethoxy)phenyl]-1,2,3,4-tetrahydro-1-(2-methylpropyl)-N-[4-[(S)-[(1-propyl-1H-imidazol-5-yl)methyl]sulfinyl]phenyl]-1-benzazocine-5-carboxamide. CAS Number: 497223-25-3. Synonyms: TAK-652. Molecular Formula: C41H52N4O4S. Formula Weight: 696.9. Purity: >95%. Formulation: (Request formulation change), A crystalline solid. Solubility: DMF: 20 mg/ml, DMSO: 20 mg/ml, DMSO:PBS (pH 7.2) (1:1): 0.5 mg/ml, Ethanol: 5 mg/ml. lambdamax: 295 nm. SMILES: CCCCOCCOC1=CC=C(C2=CC=C(N(CC(C)C)CCC/C(C(NC3=CC=C([S@](CC4=CN=CN4CCC)=O)C=C3)=O)=C\5)C5=C2)C=C1. InChi Code: InChI=1S/C41H52N4O4S/c1-5-7-22-48-23-24-49-38-15-10-32(11-16-38)33-12-19-40-35(25-33)26-34(9-8-21-44(40)28-31(3)4)41(46)43-36-13-17-39(18-14-36)50(47)29-37-27-42-30-45(37)20-6-2/h10-19,25-27,30-31H,5-9,20-24,28-29H2,1-4H3,(H,43,46)/b34-26+/t50-/m0/s1. InChi Key: PNDKCRDVVKJPKG-WHERJAGFSA-N.
Schlagworte: TAK-652, 8-[4-(2-butoxyethoxy)phenyl]-1,2,3,4-tetrahydro-1-(2-methylpropyl)-N-[4-[(S)-[(1-propyl-1H-imidazol-5-yl)methyl]sulfinyl]phenyl]-1-benzazocine-5-carboxamide
Hersteller: Cayman Chemical
Hersteller-Nr: 23927

Eigenschaften

Anwendung: Antiviral, CCR5 / CCR2 antagonist
MW: 696.9 D
Formel: C41H52N4O4S
Reinheit: >95%
Format: Crystalline Solid

Datenbank Information

CAS : 497223-25-3| Passende Produkte
KEGG ID : K04180 | Passende Produkte

Handhabung & Sicherheit

Lagerung: -20°C
Versand: -20°C (International: -20°C)
Signalwort: Warning
GHS-Piktogramme:
H-Sätze: H302, H315, H319, H335
P-Sätze: P261, P264, P270, P271, P280, P301+310, P302+352, P304+340, P305+351+338, P312, P321, P330, P332+313, P337+313, P362+364, P403+233, P405, P501
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Cenicriviroc"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen